Legalizing Psychedelics From New York To Washington And Five In Between: Which State Will Go First?
From state-regulated psychedelic therapy programs to the legalization of Schedule I substances, the spectrum is broad. We can only hope that they will bring a good dose of debate to the table.
Illinois’ new Compassionate Use and Research of Entheogens (CURE) Act would create a state-regulated psychedelic-assisted therapy program for adults over 18.
Therapy would be provided by a trained facilitator at a licensed service center, and criminal penalties for psilocybin possession would be removed, though it does not allow recreational sales.
Virginia has two psychedelic reform pieces.
HB 1513 would legalize psilocybin possession for holders of a health professional prescription for the treatment of three conditions (refractory depression, PTSD or end-of-life anxiety) protect doctors and pharmacists distributing the psychedelic from prosecution, and amend state drug laws making non-medical possession of psilocybin a class 2 misdemeanor.
This proposal has recently been turned down by Virginia legislators, as they ultimately decided to lay it on the table.
SB 932 requests state-level reclassification of psilocybin from Schedule I to Schedule III. It also calls stipulates a new state psilocybin advisory board must develop a long-term strategic plan for establishing therapeutic access to psilocybin services.
Continue reading on the other proposals –New York, Washington, Connecticut, New Hampshire and Arizona’s– with exclusive comments by specialized cannabis and psychedelics lawyer Joshua Kappel.
Finally, two other states are moving towards psychedelics decriminalization: a Missouri bill would legalize psilocybin therapy, while New Jersey’s …